Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ChemoCentryx Regains Crohn’s Candidate Vercirnon From GSK

Sep 18 2013

Related Content

GSK/ChemoCentryx Crohn’s Failure May Sink Hefty Phase III Program

Aug 23 2013

Related Companies

GSK plc

ChemoCentryx, Inc.

Bio-Techne Corporation

Additional Topics

United States Clinical Trials Deals BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window